# Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages

> **NCT04177043** · PHASE4 · COMPLETED · sponsor: **Egyptian Liver Hospital** · enrollment: 221855 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DIAGNOSTIC_TEST:** HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests
- **DRUG:** DAAs

## Key facts

- **NCT ID:** NCT04177043
- **Lead sponsor:** Egyptian Liver Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-12
- **Target enrollment:** 221855 (ACTUAL)
- **Last updated:** 2019-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04177043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04177043, "Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04177043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*